Literature DB >> 21881208

T cell killing by tolerogenic dendritic cells protects mice from allergy.

Ulrike Luckey1, Marcus Maurer, Talkea Schmidt, Nadine Lorenz, Beate Seebach, Martin Metz, Kerstin Steinbrink.   

Abstract

It is well established that allergy development can be prevented by repeated low-dose exposure to contact allergens. Exactly which immune mechanisms are responsible for this so-called low zone tolerance (LZT) is not clear, although CD8⁺ suppressor T cells are known to have a role. Here, we show that TNF released by tolerogenic CD11⁺CD8⁺ DCs located in skin-draining lymph nodes is required and sufficient for development of tolerance to contact allergens in mice. DC-derived TNF protected mice from contact allergy by inducing apoptosis in allergen-specific effector CD8⁺ T cells via TNF receptor 2 but did not contribute to the generation and function of the regulatory T cells associated with LZT. The TNF-mediated killing mechanism was induced in an allergen-specific manner. Activation of tolerogenic DCs by LZT CD8⁺ suppressor T cells and enhanced TNF receptor 2 expression on contact allergen-specific CD8⁺ effector T cells were required for LZT. Our findings may explain how tolerance protects from allergic diseases, which could allow for the development of new strategies for allergy prevention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881208      PMCID: PMC3195460          DOI: 10.1172/JCI45963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  Cellular mechanisms of TNF function in models of inflammation and autoimmunity.

Authors:  Maria Apostolaki; Maria Armaka; Panayiotis Victoratos; George Kollias
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

Review 2.  Natural killer or dendritic: what's in a name?

Authors:  Hergen Spits; Lewis L Lanier
Journal:  Immunity       Date:  2007-01       Impact factor: 31.745

Review 3.  Tolerogenic dendritic cells and the quest for transplant tolerance.

Authors:  Adrian E Morelli; Angus W Thomson
Journal:  Nat Rev Immunol       Date:  2007-07-13       Impact factor: 53.106

Review 4.  New aspects of the molecular basis of contact allergy.

Authors:  Andrea Cavani; Ornella De Pità; Giampiro Girolomoni
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-10

5.  Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators.

Authors:  Geertje J D van Mierlo; Hans U Scherer; Marjolijn Hameetman; Mary E Morgan; Roelof Flierman; Tom W J Huizinga; René E M Toes
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 6.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

7.  Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.

Authors:  Jeroen N Stoop; Andrea M Woltman; Paula J Biesta; Johannes G Kusters; Ernst J Kuipers; Harry L A Janssen; Renate G van der Molen
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

8.  Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.

Authors:  Suchita Nadkarni; Claudia Mauri; Michael R Ehrenstein
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

9.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

10.  Expression and function of TNF and IL-1 receptors on human regulatory T cells.

Authors:  Frances Mercer; Lina Kozhaya; Derya Unutmaz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more
  12 in total

1.  Allergy: Peaceful death ends pain.

Authors:  Yvonne Bordon
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

Review 2.  Novel immunoregulatory role of perforin-positive dendritic cells.

Authors:  Ran Orgad; Bar Nathansohn-Levi; Sivan Kagan; Yael Zlotnikov Klionsky; Yair Reisner
Journal:  Semin Immunopathol       Date:  2016-08-30       Impact factor: 9.623

Review 3.  The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity.

Authors:  Nils Scheib; Jessica Tiemann; Christian Becker; Hans Christian Probst; Verena Katharina Raker; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

Review 4.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

5.  Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity.

Authors:  Christian T Mayer; Luciana Berod; Tim Sparwasser
Journal:  Front Immunol       Date:  2012-07-03       Impact factor: 7.561

Review 6.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

7.  Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.

Authors:  Paulina A García-González; Katina Schinnerling; Alejandro Sepúlveda-Gutiérrez; Jaxaira Maggi; Lorena Hoyos; Rodrigo A Morales; Ahmed M Mehdi; Hendrik J Nel; Lilian Soto; Bárbara Pesce; María Carmen Molina; Miguel Cuchacovich; Milton L Larrondo; Óscar Neira; Diego Francisco Catalán; Catharien M Hilkens; Ranjeny Thomas; Ricardo A Verdugo; Juan C Aguillón
Journal:  Front Immunol       Date:  2016-10-25       Impact factor: 7.561

Review 8.  Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.

Authors:  Ling Xiao; Belinda Van't Land; Wouter R P H van de Worp; Bernd Stahl; Gert Folkerts; Johan Garssen
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

9.  Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

Authors:  Sébastien Anguille; Eva Lion; Jurjen Tel; I Jolanda M de Vries; Karen Couderé; Phillip D Fromm; Viggo F Van Tendeloo; Evelien L Smits; Zwi N Berneman
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 10.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.